12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

GlycoMimetics preclinical data

In a mouse model of non-occlusive thrombosis, 10 mg/kg GMI-1271 significantly reduced venous thrombus formation vs. sham-treated controls (p=0.0271). The active control enoxaparin...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >